Arslan B, Pacaci Cetin G, Turk M, Gulmez I, et al. Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide Discontinuing Omalizumab Treatment? Int Arch Allergy Immunol 2022 Aug 2:1-7. doi: 10.1159/000525723.
PMID: 35917798